Actively Recruiting
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2024-11-13
440
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.
CONDITIONS
Official Title
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Migraine patients diagnosed according to ICHD-3 criteria
- Healthy controls matched by age and sex without headaches
- Healthy controls without first degree family history of headache
- Age between 6 and 75 years
You will not qualify if you...
- Having any major medical or neurological illness
- Having any salivary gland malfunction
- Abuse or dependence on tobacco, alcohol, or any drug within 12 months before enrollment
- Currently receiving active migraine preventive treatment
- Being pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vall d'Hebron University Hospital
Barcelona, Barcelona, Spain, 08035
Actively Recruiting
Research Team
P
Patricia Pozo-Rosich, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here